MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Passage Bio, Inc. (NASDAQ PASG)
Organization & Developments: Passage Bio
Parents
Passage Bio, Inc. (NASDAQ PASG)
Children
*Passage Bio is a genetic medicines company developing transformative therapies for the treatment of rare monogenic central nervous system disorders
2020: Passage Bio To IPO Soon, Promising Gene Therapy Pipeline Against Rare Diseases_seekingalpha.com
2021: Our First Peek At Passage Bio
2021: Roiled by senior-level exits, Jim Wilson’s Passage Bio retrenches, chopping back on staff as it extends cash runway
2022: Passage Bio, Inc. 2022 Q3 - Results - Earnings Call Presentation_seekingalpha.com
Jumps
*Key People: Passage Bio
Finance & Acquisitions: Passage Bio